Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,459,978
-$13,288,385 QoQ
Shares Held
142,366
-75.7% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#102
of 421 holders
Holding Since
Mar 2021
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Derivatives in ALKS
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$11,743,206
PutShares
419,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $126,095,704 across 18 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
277,821 | $30,821,461 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
309,682 | $19,804,163 | |
| 3 | BIOA |
BioAge Labs, Inc.
|
702,858 | $17,227,049 | |
| 4 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
684,974 | $12,302,133 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
511,336 | $8,196,716 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
218,958 | $7,591,273 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
434,132 | $7,514,824 | |
| 8 | ALKS |
Alkermes plc.
This page
|
142,366 | $7,459,978 |
All Filings in ALKS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,459,978 | 142,366 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $20,748,363 | 586,775 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,743,206 | 419,700 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $19,016,131 | 679,633 | Shares | Sole | 2026-02-17 | |
| 2024-06-30 | $324,723 | 13,474 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $13,038,427 | 481,656 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $451,717 | 16,284 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $360,768 | 12,880 | Shares | Other | 2023-11-14 | |
| 2023-03-31 | $22,159,227 | 786,067 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $46,065,803 | 1,762,947 | Shares | Other | 2023-02-14 | |
| 2022-03-31 | $5,293,151 | 201,184 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $4,960,089 | 160,833 | Shares | Sole | 2021-12-01 | |
| 2021-03-31 | $7,285,200 | 390,000 | Call | Sole | 2021-05-17 | |
| 2021-03-31 | $9,930,755 | 531,625 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||